Spiramycin

For research use only. Not for therapeutic Use.

  • CAT Number: R004364
  • CAS Number: 8025-81-8
  • Molecular Formula: C43H74N2O14 (Spiramycin I, R = H)
  • Molecular Weight: 843.10
  • Purity: ≥95%
Inquiry Now

Cefacetrile(Cat No.:R004364)is a broad-spectrum cephalosporin antibiotic used for the treatment of various bacterial infections. It is effective against both Gram-positive and Gram-negative organisms, including staphylococci, streptococci, and certain enterobacteria. Cefacetrile works by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. It is commonly prescribed for respiratory, urinary tract, and skin infections. Administered via intravenous or intramuscular injection, cefacetrile demonstrates high stability in the presence of β-lactamases, making it a reliable option in resistant bacterial strains. It is generally well-tolerated with minimal side effects.


Catalog Number R004364
CAS Number 8025-81-8
Synonyms

Formacidine;NSC 55926;Rovamycine

Molecular Formula C43H74N2O14 (Spiramycin I, R = H)
Purity ≥95%
Target Bacterial
Storage 2-8°C
IUPAC Name 2-[(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-[(2S,3R,4R,5S,6R)-5-[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyloxan-2-yl]oxy-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-10-[(2R,5S,6R)-5-(dimethylamino)-6-methyloxan-2-yl]oxy-4-hydroxy-5-methoxy-9,16-dimethyl-2-oxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde
InChI InChI=1S/C43H74N2O14/c1-24-21-29(19-20-46)39(59-42-37(49)36(45(9)10)38(27(4)56-42)58-35-23-43(6,51)41(50)28(5)55-35)40(52-11)31(47)22-33(48)53-25(2)15-13-12-14-16-32(24)57-34-18-17-30(44(7)8)26(3)54-34/h12-14,16,20,24-32,34-42,47,49-51H,15,17-19,21-23H2,1-11H3/b13-12+,16-14+/t24-,25-,26-,27-,28+,29+,30+,31-,32+,34+,35+,36-,37-,38-,39+,40+,41+,42+,43-/m1/s1
InChIKey ACTOXUHEUCPTEW-CEUOBAOPSA-N
SMILES C[C@@H]1C/C=C/C=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)OC)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O[C@H]3C[C@@]([C@H]([C@@H](O3)C)O)(C)O)N(C)C)O)CC=O)C)O[C@H]4CC[C@@H]([C@H](O4)C)N(C)C
Reference

<p>Lovmar, Martin, and Tanel Tenson. /The Mechanism of Action of Macrolides, Lincosamides and Streptogramin B Reveals the Nascent Peptide Exit Path in the Ribosome./<em>Journal of Molecular Microbiology</em> 330.5 (2003): 1005-014.</p></span></p>

Request a Quote